Landmark clinical trials are trials that have significantly influenced clinical practice, and there are several clinical trials that are well known for their implications in diabetes prevention and control. Kim Kelly, PharmD, BCPS, FCCP, CDTC, CPC, CEC presents the landmark clinical trials that have most influenced the clinical practice of diabetes.
An exercise prescription is a way to incorporate the critical component of physical activity into the diabetes self-management plan for people with diabetes. Gary Scheiner, MS, CDCES shares his expertise in this area. Gary describes the essential role physical activity plays in diabetes management, reviews strategies to minimize risks associated with physical activity in people with diabetes and provides the tools necessary to design individualized physical activity plans for people with diabetes.
Lifestyle changes and oral medications are standards of care in type 2 diabetes management, but are unlikely to be permanent solutions because type 2 diabetes is a progressive disease. Most people with type 2 diabetes will eventually require insulin to achieve euglycemia. Elaine Cooke, BSc(Pharm), RPh, CDCES shares her experience as a healthcare professional in Canada with insulin initiation and titration in type 2 diabetes
Population health management is designed to improve the health of a defined patient population and relies on the ability to provide individualized support at and between clinic visits. Teresa Pearson, MS, RN, CDCES, FADCES discusses population-level strategies to organize and deliver care to people with diabetes.
People with diabetes are frequently admitted to the hospital and are more likely to have longer durations of hospital stay than people without diabetes. Controlling glucose levels during hospitalizations is vitally important since uncontrolled hyperglycemia is associated with adverse outcomes. Jane Jeffrie Seley, DNP, MSN, MPH, GNP, BC-ADM, CDCES, CDTC, FAAN discusses the treatment of people with diabetes who are admitted to general floors of the hospital.
Diabetes is a challenging disease to manage due to the multitude of therapeutic recommendations and the need for lifelong adherence. Reasons for non-adherence are multi-factorial, difficult to identify, and common in individuals with diabetes, which makes target glycemic control difficult to attain.
Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials